Drug factory · FDA FEI 3000219354
IDT Australia Limited
39-57 Wadhurst Drive, Boronia, Australia
Problems found, fixed voluntarily at FDA's last inspection, Mar 28, 2025.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
6 drug inspections on record since 2009: 0 with no problems, 5 with problems fixed voluntarily, 1 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Minocycline | Makes the active ingredient and tests it | Melinta Therapeutics, LLC | 70842-160 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 28, 2025 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 31, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Dec 8, 2017 | Serious problems, FDA action | Drug Quality Assurance | — |
| Jan 19, 2015 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 21, 2013 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 21, 2009 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture; label; manufacture; pack.